Report on the Review of Sales Transactions for Oxycodone-based Products in Atlantic Canada (Retail Pharmacies only)

7. Volume of Transactions Distributed by Product

7.1 Volume of transactions by product. total quantity of products and contribution ratios

7.1.1 Regional

This section presents a table showing the regional contributions of oxycodone-based products to the volume of transactions and quantity of products for Atlantic Canada.

Table 4: Oxycodone-based products sorted by volume of transactions, Atlantic Canada

Atlantic Canada
Product	Strength (mg)	Volume of Transactions	Quantity of Products	Avg Qty of Products per Transaction	Reg Ctr Vol (%)	Reg Ctr Qty (%)
Endocet	5	40,406	2,976,218	74	43.7	44.7
Ratio-Oxycocet	5	10,734	792,212	74	11.6	11.9
Percocet	5	8,879	562,108	63	9.6	8.4
Oxycontin-Srt	20	8,649	590,250	68	9.3	8.9
Oxycontin-Srt	40	6,190	416,581	67	6.7	6.3
Oxycontin-Srt	10	5,850	379,607	65	6.3	5.7
Pms-Oxy-Aceta	5	2,536	162,974	64	2.7	2.4
Oxycontin-Srt	80	2,457	195,127	79	2.7	2.9
Oxy-Ir	10	1,596	136,402	85	1.7	2.0
Oxy-Ir	5	1,186	88,328	74	1.3	1.3
Oxy-Ir	20	1,067	105,336	99	1.2	1.6
Endodan	5	993	75,820	77	1.1	1.1
Percocet-Demi	2,5	875	44,504	51	0.9	0.7
Supeudol	10	450	78,348	174	0.5	1.2
Percodan	5	298	21,979	74	0.3	0.3
Ratio-Oxycodan	5	200	20,953	105	0.2	0.3
Supeudol	5	168	13,906	83	0.2	0.2
Percodan-Demi	2,5	3	140	47	0.0	0.0
Supeudol Supp	10	1	84	84
Total		92,538	6,660,877	72	100	100

7.1.2 Provincial

This section presents tables showing regional and provincial contributions of oxycodone-based products to the volume of transactions and quantity of products for each province. Provinces are presented in descending order of volume of transactions as per Table 3.

Table 5: Oxycodone-based products sorted by volume of transactions, New Brunswick

New Brunswick
Product	Strength	Volume of Transactions	Quantity of Tablets	Avg Qty of Tablets per Transaction	Prov Ctr Vol (%)	Prov Ctr Qty (%)	Reg Ctr Vol (%)	Reg Ctr Qty (%)
Endocet	5	25,935	1,821,748	70	64.1	64.5	28.0	27.3
Oxycontin-Srt	20	3,579	244,294	68	8.8	8.6	3.9	3.7
Oxycontin-Srt	10	2,707	173,310	64	6.7	6.1	2.9	2.6
Oxycontin-Srt	40	2,569	174,938	68	6.3	6.2	2.8	2.6
Ratio-Oxycocet	5	1,801	113,357	63	4.5	4.0	1.9	1.7
Oxycontin-Srt	80	1,082	77,508	72	2.7	2.7	1.2	1.2
Oxy-Ir	10	615	52,408	85	1.5	1.9	0.7	0.8
Oxy-Ir	5	555	41,072	74	1.4	1.5	0.6	0.6
Percocet	5	445	36,407	82	1.1	1.3	0.5	0.5
Percocet-Demi	2,5	443	18,929	43	1.1	0.7	0.5	0.3
Oxy-Ir	20	297	32,663	110	0.7	1.2	0.3	0.5
Endodan	5	282	20,303	72	0.7	0.7	0.3	0.3
Supeudol	10	48	7,801	163	0.1	0.3	0.1	0.1
Ratio-Oxycodan	5	46	4,755	103	0.1	0.2	0.0	0.1
Supeudol	5	27	2,589	96	0.1	0.1	0.0	0.0
Percodan	5	23	1,973	86	0.1	0.1	0.0	0.0
Pms-Oxy-Aceta	5	2	530	265	0.0	0.0	0.0	0.0
Percodan-Demi	2,5	2	120	60	0.0	0.0	0.0	0.0
Total		40,458	2,824,705	70	100	100	43.7	42.4

 

Table 6: Oxycodone-based products sorted by volume of transactions, Nova Scotia

Nova Scotia
Product	Strength	Volume of Transactions	Quantity of Tablets	Avg Qty of Tablets per Transaction	Prov Ctr Vol (%)	Prov Ctr Qty (%)	Reg Ctr Vol (%)	Reg Ctr Qty (%)
Endocet	5	14,246	1,138,518	80	57.4	55.2	15.4	17.1
Oxycontin-Srt	20	2,264	180,229	80	9.1	8.7	2.4	2.7
Oxycontin-Srt	40	1,675	130,900	78	6.7	6.4	1.8	2.0
Oxycontin-Srt	10	1,545	125,260	81	6.2	6.1	1.7	1.9
Ratio-Oxycocet	5	1,057	97,179	92	4.3	4.7	1.1	1.5
Endodan	5	711	55,517	78	2.9	2.7	0.8	0.8
Oxy-Ir	10	636	58,531	92	2.6	2.8	0.7	0.9
Percocet	5	557	53,319	96	2.2	2.6	0.6	0.8
Oxycontin-Srt	80	455	43,486	96	1.8	2.1	0.5	0.7
Oxy-Ir	5	408	32,785	80	1.6	1.6	0.4	0.5
Percocet-Demi	2,5	406	24,473	60	1.6	1.2	0.4	0.4
Oxy-Ir	20	368	39,687	108	1.5	1.9	0.4	0.6
Supeudol	10	301	60,420	201	1.2	2.9	0.3	0.9
Supeudol	5	92	10,242	111	0.4	0.5	0.1	0.2
Percodan	5	63	6,281	100	0.3	0.3	0.1	0.1
Ratio-Oxycodan	5	44	4,372	99	0.2	0.2	0.0	0.1
Total		24,828	2,061,199	83	100	100	26.8	30.9

 

Table 7: Oxycodone-based products sorted by volume of transactions, Newfoundland and Labrador

Newfoundland and Labrador
Product	Strength	Volume of Transactions	Quantity of Tablets	Avg Qty of Tablets per Transaction	Prov Ctr Vol (%)	Prov Ctr Qty (%)	Reg Ctr Vol (%)	Reg Ctr Qty (%)
Percocet	5	7,805	468,080	60	40.9	40.6	8.4	7.0
Pms-Oxy-Aceta	5	2,534	162,444	64	13.3	14.1	2.7	2.4
Oxycontin-Srt	20	1,964	98,590	50	10.3	8.6	2.1	1.5
Ratio-Oxycocet	5	1,836	126,895	69	9.6	11.0	2.0	1.9
Oxycontin-Srt	40	1,685	90,741	54	8.8	7.9	1.8	1.4
Oxycontin-Srt	10	1,178	48,953	42	6.2	4.2	1.3	0.7
Oxycontin-Srt	80	804	63,322	79	4.2	5.5	0.9	1.0
Oxy-Ir	20	399	32,546	82	2.1	2.8	0.4	0.5
Oxy-Ir	10	299	21,565	72	1.6	1.9	0.3	0.3
Percodan	5	208	13,325	64	1.1	1.2	0.2	0.2
Oxy-Ir	5	168	10,491	62	0.9	0.9	0.2	0.2
Supeudol	10	99	9,527	96	0.5	0.8	0.1	0.1
Supeudol	5	48	1,045	22	0.3	0.1	0.1	0.0
Percocet-Demi	2.5	22	1,018	46	0.1	0.1	0.0	0.0
Ratio-Oxycodan	5	21	2,292	109	0.1	0.2	0.0	0.0
Endocet	5	11	1,484	135	0.1	0.1	0.0	0.0
Supeudol	10	1	84	84	0.0	0.0	0.0	0.0
Percodan-Demi	2.5	1	20	20	0.0	0.0	0.0	0.0
Total		19,083	1,152,422	60	100	100	20.6	17.3

 

Table 8: Oxycodone-based products sorted by volume of transactions. Prince Edward Island

Prince Edward Island
Product	Strength	Volume of Transactions	Quantity of Tablets	Avg Qty of Tablets per Transaction	Prov Ctr Vol (%)	Prov Ctr Qty (%)	Reg Ctr Vol (%)	Reg Ctr Qty (%)
Ratio-Oxycocet	5	6,040	454,781	75	73.9	73.1	6.5	6.8
Oxycontin-Srt	20	842	67,137	80	10.3	10.8	0.9	1.0
Oxycontin-Srt	10	420	32,084	76	5.1	5.2	0.5	0.5
Oxycontin-Srt	40	261	20,002	77	3.2	3.2	0.3	0.3
Endocet	5	214	14,468	68	2.6	2.3	0.2	0.2
Oxycontin-Srt	80	116	10,811	93	1.4	1.7	0.1	0.2
Ratio-Oxycodan	5	89	9,534	107	1.1	1.5	0.1	0.1
Percocet	5	72	4,302	60	0.9	0.7	0.1	0.1
Oxy-Ir	5	55	3,980	72	0.7	0.6	0.1	0.1
Oxy-Ir	10	46	3,898	85	0.6	0.6	0.0	0.1
Percocet-Demi	2.5	4	84	21	0.0	0.0	0.0	0.0
Percodan	5	4	400	100	0.0	0.1	0.0	0.0
Oxy-Ir	20	3	440	147	0.0	0.1	0.0	0.0
Supeudol	10	2	600	300	0.0	0.1	0.0	0.0
Supeudol	5	1	30	30	0.0	0.0	0.0	0.0
Total		8,169	622,551	76	100	100	8.8	9.3